Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 11,575

Document Document Title
WO/2017/180591A1
The invention provides nanozymes that accumulate in the kidney and methods for their use.  
WO/2017/174744A1
A delivery system comprising hydrogen peroxide or a hydrogen peroxide generator system, for use in a method for the treatment or prevention of inflammatory bowel disease in a mammal, is described. The method comprises a step of orally ad...  
WO/2017/170762A1
The purpose of the present invention is to provide a tablet having sufficient strength and containing spherical adsorptive carbon for oral administration. This purpose is met with a tablet that contains spherical adsorptive carbon for or...  
WO/2017/170764A1
The purpose of the present invention is to provide a tablet, and a production method thereof, which has a high absorption rate of spherical adsorptive carbon for oral administration, and a high uniformity of the spherical adsorptive carb...  
WO/2017/169652A1
The method for producing polyphenols according to one embodiment of the present invention comprises a step for mixing used tea leaves with water to generate a liquid mixture. The liquid mixture is heated. From the heated liquid mixture, ...  
WO/2017/160864A1
The present invention includes a method of protecting or treating neural cells from degeneration comprising: identifying a neural cell in need of protection from at least one of radical oxidative stress, increased mitochondrial biogenesi...  
WO/2017/158041A1
The present invention relates to compositions comprising at least one film- forming agent able to adhere in a stable way to the mucosa of the mouth, esophagus and upper airways, establishing a mechanical form of protection against attack...  
WO/2017/159554A1
The invention provides a crystal of glutathione having excellent flowability and pulverizability, and a method for producing the same. The invention relates to a crystal of reduced-form glutathione, wherein the average crystal thickness ...  
WO/2017/159555A1
The purpose of the invention is to provide: a crystal of reduced-form glutathione in which the content of impurities, particularly L-cysteinyl-L-glycine, is reduced; and a method for producing the same. The invention relates to a crystal...  
WO/2017/157350A1
An edaravone dosage form and a use thereof in preparing a drug used for treating diseases related to oxidative stress, the dosage form being selected from a lipid-based delivery system, a solid dispersion, micelles and a solubilising age...  
WO/2017/152237A1
The present invention relates to new Desferrioxamine B-based compounds that are useful for iron-chelation therapy, to their preparation, and to compositions including the compounds. The present invention also relates to the use of the co...  
WO/2017/152718A1
Disclosed are an injection comprising chlorine dioxide for use in the therapeutic goals of promoting the regeneration of stem cells in vivo, and being anti-tumour and anti-ageing, etc., and a preparation method therefor. The injection ha...  
WO/2017/150409A1
Provided is a cacao extract with better flavor and in which off-flavor is suppressed, and a method for manufacturing such a cacao extract. The cacao water extract of the present invention contains polyphenol. In this cacao water extract,...  
WO/2017/152114A1
A tumescent contravenom solution including: (a) a vasoconstrictor, (b) a physiological crystalloid solution, and (c) optionally a contravenom agent that neutralizes tissue toxic enzymes present in a venom and/or a drug that impairs or pa...  
WO/2017/148183A1
Disclosed are a compound traditional Chinese medicine composition containing gynostemma pentaphyllum and a preparation method thereof. The compound traditional Chinese medicine composition containing gynostemma pentaphyllum is made of gy...  
WO/2017/147505A1
Provided are methods of treating muscle and liver disorders, and for increasing mitochondrial mass and/or functionality in a mammalian myocyte and/or hepatocyte.  
WO/2017/147263A1
The present invention relates to an isolated recombinant human lipidated survivin expressed in an Escherichia coli-based system. The isolated recombinant human lipidated survivin augments the expression levels of costimulatory molecules ...  
WO/2017/147522A1
The present disclosure relates to solutions and methods of preparing lyophilized formulations of factor Xa (fXa) antidotes. A suitable aqueous formulation suitable for lyophilization can include a fXa antidote, a solubilizing agent, and ...  
WO/2017/142961A1
The present invention provides a method for treating neurodegenerative disease, traumatic brain injury, or stroke. In particular, the present invention provides a method for using a glycopeptide PACAP/VIP analogues with enhanced CNS pene...  
WO/2017/138626A1
A nerve growth promoter and an antioxidant containing a digested product obtained by using a protease to digest a composition containing hyaluronic acid and a protein. A wound treatment agent containing an ethyl acetate extract from a di...  
WO/2017/135286A1
Provided are an urolithins-containing aqueous solution comprising urolithins and collagen, a dried solid composition thereof, and a production method therefor, and an urolithins stabilizing method.  
WO/2017/133037A1
A health care liquid capable of enhancing human immunity and resisting against ageing comprises, by mass percent, 30% to 60% of original plant juice, 3% to 8% of wine bases, 0 to 15% of auxiliary materials and the balance water. The orig...  
WO/2017/135466A1
The present invention relates to a novel composition containing xanthophyll, or a salt thereof, and a processed product of a Trapa genus plant, and to a novel ophthalmic composition containing a processed product of a Trapa genus plant. ...  
WO/2017/129132A1
Provided is a healthcare hot compress Chinese medicine bag comprising a Chinese medicine composition and a pharmaceutical bag for packaging the Chinese medicine. The Chinese medicine composition is made from the following components by w...  
WO/2017/130709A1
One solid preparation of the present invention has fine silicon particles as a principal component thereof, and exhibits a hydrogen generation capacity. In addition, one embodiment of this solid preparation has fine silicon particles whi...  
WO/2017/131127A1
Provided are: a novel bisphosphonic acid compound which exhibits prominent inhibitory activity against ectopic calcification, or a salt thereof; and a pharmaceutical composition containing the compound or salt thereof. The bisphosphonic ...  
WO/2017/125080A1
Provided is an application of a fullerene / metal-fullerene micro/nanomaterial for preparing a pharmaceutical product. The pharmaceutical product has at least one of the following properties: 1) treats a bone marrow suppression; 2) treat...  
WO/2017/125498A1
The ratio of the metals zincand cadmium is of great significance for error-free proliferation and differentiation of cells. An understanding of the role of cadmium in the etiology of cancer offers possibilities to gain a better understan...  
WO/2017/126708A1
The purpose of the present invention is to provide a prophylactic or therapeutic agent for oxidative stress damages, which is intended to be administered during phacoemulsification and aspiration for cataract. The present invention is a ...  
WO/2017/124921A1
The present invention provides a walnut oligopeptide powder, and a preparation method and application thereof. The oligopeptide powder has a peptide content of 80 wt% or higher, wherein 95% or more of the peptides have a molecular weight...  
WO/2017/122120A1
Methods, formulations and kits for treating and/or protecting against acute liver failure and other hepatotoxicities in an individual employ a combination of a first active agent which replenishes, or decreases a loss of, functional glut...  
WO/2017/123823A1
This application discloses compounds and pharmaceutical compositions and methods of using the same for inhibition of sulfide:quinone oxidoreductase (SQOR).  
WO/2017/114992A1
The invention relates to a method for producing an extract containing hydroxycinnamic acids, characterised in that the method uses one or more vegetable waste products from the production of vegetable food products as a raw material, and...  
WO/2017/115705A1
[Problem] To provide a medicinal composition that is capable of improving the prognosis after the restart of the patient's own heartbeat even after the passage of a considerably long period of time after the restart of the patient's own ...  
WO/2017/107628A1
The present disclosure belongs to the technical field of pharmaceutical preparations and specifically relates to a chitosan oligosaccharide capsule and method for preparation thereof. The chitosan oligosaccharide capsule comprises conten...  
WO/2017/101793A1
The invention belongs to the field of biomedical research involving the 1, 3, 4- selenyldiazo derivatives that have cell protective activity. Because there are not so many heterocyclic selenium compounds, we synthesized a new type of sel...  
WO/2017/103348A1
The invention relates to a liquid composition comprising at least one mucosa-lining agent, at least one humectant, and at least one pH adjuster. The invention also relates to the use of said composition as a nasal solution in the prevent...  
WO/2017/104777A1
A purpose of the present invention is to provide: a composition for inhibiting carnosine dipeptidase, use of said composition for inhibiting carnosine dipeptidase, and a method for inhibiting carnosine dipeptidase. Another purpose of the...  
WO/2017/100915A1
There is provided an improved extraction process for obtaining integral & active thylakoid membranes that have longer shelf-life at room temperature. Particularly, the extract is lyophilized in a solution of PVP and remains stable with a...  
WO/2017/101887A1
A healthcare pharmaceutical preparation having magnesium supplementation and anti-oxidation effects, and a preparation method for the healthcare pharmaceutical preparation. The healthcare pharmaceutical preparation comprises a main effec...  
WO/2017/101873A1
An application of plasminogen for preventing, treating, improving and/or eliminating radiation and chemical damage and associated diseases in a subject, further providing a novel treatment strategy for treating different types of radiati...  
WO/2017/097182A1
The present invention discloses quinoline compounds, a preparation method thereof, and a use thereof as a urate transporter inhibitor drug. The compounds and salts, hydrates or solvates thereof provided in the present invention, as a sel...  
WO/2017/095489A1
This invention generally relates to a composition and method for inducing the expansion and/or regeneration of CD34-positive adult stem cell population, which is useful for developing drugs/vaccines and/or therapies against a variety of ...  
WO/2017/095458A1
This invention generally relates to a composition and method of using recombinant microRNAs (miRNA) and their hairpin-like precursors (pre-miRNA) as therapeutic drugs for treating Alzheimer's diseases (AD). More specifically, the present...  
WO/2017/094549A1
Provided are a novel ultraviolet-ray screening agent and a novel cosmetic each having a high level of ultraviolet-ray screening function. The inventors have found that an extract from an olive branch has a high level of effect of absorbi...  
WO/2017/092638A1
The present invention relates to an opioid receptor antagonist derivative, a preparation method thereof and a use thereof in medicine. In particular, the present invention relates to a naloxone derivative as shown by general formula (I) ...  
WO/2017/084431A1
The present invention provides a composition for removing harmful reactive oxygen from a human body, which is composed of 7-hydroxycoumarin for removing superoxide radical O2 and resveratrol for removing hydrogen peroxide H2O2, the 7-hyd...  
WO/2017/087795A1
This invention relates to novel α-tocotrienol quinones of Formula I: (I), and pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions ...  
WO/2017/080669A1
The present invention provides a pharmaceutical preparation for use by injection into the skin, wherein the pharmaceutical preparation is preparable by a production method comprising the steps of providing a liquid collected from an orga...  
WO/2017/080668A1
The present invention relates a pharmaceutical preparation for the treatment of age- related disorders, which is preparable by a production method comprising the following steps: providing a liquid collected from an organism, which liqui...  

Matches 1 - 50 out of 11,575